Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Com-COV Study Group"'
Autor:
Shaw, RH, Liu, X, Stuart, ASV, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Dejnirattisai, W, Dinesh, T, Faust, SN, Ferreira, DM, Finn, A, Green, CA, Hallis, B, Heath, PT, Hill, H, Lambe, T, Lazarus, R, Libri, V, Long, F, Mujadidi, YF, Plested, EL, Morey, ER, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, P, Vichos, J, Walker, LL, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV Study Group
Background: Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which may influence immune persistence and the relative importance of third-dose ‘booster’ programmes. Here, we report on the impact of 4- versus 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::8f66cb109597a51f09db4bdb89875e25
http://hdl.handle.net/10044/1/96621
http://hdl.handle.net/10044/1/96621
Autor:
Shaw, Robert H1 (AUTHOR), Stuart, Arabella1 (AUTHOR), Greenland, Melanie1 (AUTHOR), Liu, Xinxue1 (AUTHOR), Van-Tam, Jonathan S Nguyen2 (AUTHOR), Snape, Matthew D1,3 (AUTHOR) matthew.snape@paediatrics.ox.ac.uk, Com-COV Study Group (CORPORATE AUTHOR)
Publikováno v:
Lancet. 5/29/2021, Vol. 397 Issue 10289, p2043-2046. 4p.
